Profile

Timeline

A history of innovation and sustainable growth

 
  • 1966

    • Aché Laboratórios Farmacêuticos S.A. is founded;
    • Moderex launch.
  • 1968

    • Combiron and Sorine launches.
  • 1969

    • Acquisition of the tract along the Presidente Dutra Highway to build the new Aché head office.
  • 1970

    • Somalium launch; Aché presents its first clinical study at the Brazilian Cardiology Congress.
  • 1973

    • Prodoctor Produtos Farmacêuticos Ltda. takeover.
    • Laboratory moves to new building on the Presidente Dutra Highway, km 222,2 in Guarulhos (SP). Conceived by renowned architect Ruy Ohtake, the Aché I project is awarded at the I São Paulo International Architecture Biennal.
  • 1979

    • Bracco-Novoterápica group acquisition, the first time ever a multinational is acquired by a Brazilian laboratory.
  • 1980

    • Aché begins to implement IT processes.
    • Tandrilax launch.
  • 1982

    • Aché acquires Parke-Davis and the right to manufacture and sell PD’s drugs.
  • 1983

    • Digeplus launch.
  • 1987

    • First research initiatives into phytomedicine through partnerships with Brazilian universities.
    • NeoDecapeptyl launch with pioneering microcapsule technology.
  • 1988

    • Prodome, joint venture established with Merck Sharp & Dohme.
  • 1989

    • Biofenac anti-inflammatory launch.
  • 1990

    • Acquisition of 42% stake in Schering-Plough Brazil.
  • 1993

    • CAC, the Customer Service Central, begins operations and Aché launches its first social-action project.
    • Aché and the Universidade de Campinas (Unicamp) develop manufacturing process for component used in the production of Triac, an obesity treatment drug and hormonal supplement for thyroid cancer patients.
  • 1994

    • Building of Guarulhos (SP) head office effluent treatment station.
  • 1995

    • Novamax antibiotic and Gastrium launches.
  • 1996

    • Aché V building opening, a management facility for the Childhood Development Center laboratory, a service for our employee’s children.
    • Aché begins to produce packaging with Braille embossing, a pioneer initiative in Latin America.
    • Notuss cough syrup  launch; product used in common cold, flu and  sore throat treatment
  • 1997

    • Record year for Aché product launches with 13 new products on the market.
    • Aché earns the right to use the esteemed Abrinq Foundation’s Child Friendly Company seal on its products.
  • 1998

    • Aché takes part in the creation of the acknowledged Instituto Ethos for corporate social responsibility.
    • Implementation of a solid waste management program at the Guarulhos (SP) head office.
  • 1999

    • Deployment of new IT system at Aché, integrating all areas within the company.
    • Quem Valoriza o Médico Valoriza a Vida campaign launch targeting physicians.
  • 2000

    • Aché attends UN Millennium Project Conference and commits to its Eight Millennium Development Goals.
    • Biofenac anti-inflammatory aerosol launch.
  • 2001

    • Aché holds its first Jornada do voluntariado volunteering campaign involving all head and branch office personnel.
    • Completion of manufacturing IT system implementation; barcode system allows for comprehensive product tracking.
    • Projeto Incluirh launch,  an initiative to integrate people with disabilities  in our organization.
  • 2002

    • Drug Donation Committee is created, benefitting charities and the underprivileged.
    • Aché’s Ombudsman Office is opened, establishing a communication channel between employees and the organization.
  • 2003

    • Opening of service  center devoted to the hearing impaired.
    • Aché sells share in Prodome joint venture.
    • Acquisition of Brazilian division of Laboratório  Asta Médica.
    • Company launches its first phytomedicine, Soyfemme, for menopause symptoms.
  • 2004

    • Acheflan registration in Brazil.
    • Implementation of company Ethical Conduct Code.
  • 2005

    • Acheflan launch in Brazil.
    • Biosintética aquisition yields entry to generics market.
  • 2006

    • Company adopts business unit management model.
  • 2007

    • Dermocosmetics market entry.
  • 2008

    • Increased internationalization with presence in 11 countries via licensing.
  • 2009

    • Partnership with Mexican pharma Silanes brings innovative diabetes drug to Brazil: Meritor.
  • 2010

    • Acquisition of 50% stake in Melcon, specialized manufacturer of hormonebased medication.
  • 2011

    • Nutraceutical market entry in partnership with UK Oxford Pharmascience.
    • Granted European patent for Acheflan, valid till 2024.
    • Company launches  its own dermocosmetics line: Profuse.
  • 2012

    • Bionovis, Brazilian  joint venture devoted to biotech drug research, begins operations.
  • 2013

    • 32 new product launches.
  • 2014

    • Acheflan Japan launch.
    • 19 new product launches.
  • 2015

    • Brand repositioning introduces new Aché slogan: Aché. Better living for you.
    • Creation of the Innovation Unit and centers for Incremental and Radical Innovation.
    • Molecular Design and Synthesis Laboratory opening.
    • 25 new product launches.
    • Partnership with Associação Maria Flos Carmeli, a charity serving underprivileged children in the downtown São Paulo (SP) Glicério district.